ACTIVE

PharmaBXL

Export PDF
Financial year 2024 · closed on 31/12/2024
Net result
241,1 k €
+189.6% YoY
Gross margin
436,2 k €
+264.9% YoY
Equity
382,1 k €
+171.1% YoY

What does PharmaBXL do?

PharmaBXL is a Private limited company incorporated in 2022. Its main activity is: Dispensing chemist in specialised stores. Its registered office is in Bruxelles.

Legal situation
● Normal situation
BCE/KBO no. / VAT
BE 0795.508.480
Incorporation
29/12/2022
Legal form
Private limited company
Registered office
Rue de la Sablonnière 17
1000 Bruxelles · BruxellesSee on map
Contributed capital
410 000,00 €
Latest accounts
31/12/2024
Activities (NACE)
47730Dispensing chemist in specialised stores· main47730Dispensing chemist in specialised stores82990Other business support service activities n.e.c.46450Wholesale of perfume and cosmetics46450Wholesale of perfume and cosmetics64200Activities of holding companies+1
Joint committees (2)
  • 0
  • 313
Signals
ProfitableSolid equityLow riskGood liquidityPositive cashflowPositive EBITDA
View the BCE/KBO Public Search record →
Health score
Available with a Rovalta subscriptionTry for 7 days
Recommended credit limit
✦ Verdict · Analyst summary
Financials

Trend over 2 financial years

20242023
Income statement
Gross margin436,2 k €-264,5 k €
EBITDA267,1 k €-270,1 k €
Operating result250,1 k €-270,1 k €
Net result241,1 k €-269,1 k €
Balance sheet
Equity382,1 k €140,9 k €
Total assets993,8 k €570,9 k €
Cash36,7 k €106 k €
Debts565,4 k €429,2 k €
Estimate

Indicative valuation

As an indication, this company is worth

between 0 € and 100 k€
See the valuation
Governance

Board of directors

Seen on filing of 31/12/2024 · 5 active

Active mandates

REMEDIA

Director · since 06 février 2023 · 0894.633.869

Represented by RAVELINGIEN JO

Active
Cercatrova

Director · since 29 décembre 2022 · 0544.887.107

Represented by VAN HAVERBEKE CHARLES

Active
FILIP GILIAS

Director · since 29 décembre 2022 · 0465.400.159

Represented by GILIAS FILIP

Active
O2C

Director · since 29 décembre 2022 · 0844.823.280

Represented by OLBRECHTS OLIVIER

Active
PharmaLegal

Director · since 29 décembre 2022 · 0541.432.719

Represented by DE FEU GEORGES

Active
At this address

Other companies at this address

CompanyCBE no.
AMPHIKTION● Active
0803.632.924
Association d'Entraide homophile - Association pour la Défense des Homophiles● Active
0413.297.105
PHARMACIE BOTANIQUE● Active
0473.905.772
PharmaOPS.BXL● Active
0804.644.494
PharmaPROP.BXL● Active
0804.643.803
PharmaVAT.BXL● Active
1009.976.866
Annual accounts

Full financial information

20242023
Type of accountMicro modelAbridged model
Start of the financial year01/01/202429/12/2022
Closing of the financial year31/12/202431/12/2023
Length of the financial year12 months13 months
Filing date30/09/202526/08/2024
General meeting30/06/202530/06/2024
Currency of the financial yearEUREUR
NBB quality labelSatisfying controlsSatisfying controls
Ratios

Financial ratios

Looking for more information about this company?

Try for 7 days
Filings

Annual accounts filings

2 filings with the NBB

ModelClosingGeneral meetingFiledLanguageDocument
Micro model31/12/202430/06/202530/09/2025DutchPDF
Abridged model31/12/202330/06/202426/08/2024DutchPDF
Estimate

Indicative valuation

Order of magnitude

As an indication, this company is worth

between 0 € and 100 k€

The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.

Discover the Business plan
Disclaimer

Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.

Governance

Board of directors

Seen on filing of 31/12/2024 · 5 active

Active mandates

REMEDIA

Director · since 06 février 2023 · 0894.633.869

Represented by RAVELINGIEN JO

Active
Cercatrova

Director · since 29 décembre 2022 · 0544.887.107

Represented by VAN HAVERBEKE CHARLES

Active
FILIP GILIAS

Director · since 29 décembre 2022 · 0465.400.159

Represented by GILIAS FILIP

Active
O2C

Director · since 29 décembre 2022 · 0844.823.280

Represented by OLBRECHTS OLIVIER

Active
PharmaLegal

Director · since 29 décembre 2022 · 0541.432.719

Represented by DE FEU GEORGES

Active
Shareholders

Ownership and network

Looking for more information about this company?

Try for 7 days
Belgian Official Gazette

Belgian Official Gazette publications

  • Registered office02/07/2026
    MAATSCHAPPELIJKE ZETEL
    PDF
  • Mandates31/03/2026
    ONTSLAGEN - BENOEMINGEN
    PDF
  • Mandates26/01/2026
    STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, …) - KAPITAAL - AANDELEN - ONTSLAGEN - BENOEMINGEN
    PDF
  • Mandates14/03/2023
    ONTSLAGEN - BENOEMINGEN
    PDF
  • Other01/02/2023
    STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, …)
    PDF
  • Other02/01/2023
    RUBRIEK OPRICHTING (NIEUWE RECHTSPERSOON, OPENING BIJKANTOOR, ENZ...)
    PDF

Source: Belgian Official Gazette

Competition

Similar companies

A company's peers, by sector and size, are included in the Business plan.

See the Business plan

Timeline

  1. 2024
    Annual accounts 2024241,1 k €↑
  2. 2023
    Annual accounts 2023-269,1 k €
  3. 29/12/2022
    IncorporationPrivate limited company